Back
The Chemours Vs. BridgeBio Pharma Industry Stock Comparison
Sell
27
CC
The Chemours
Last Price:
$19.90
Seasonality Move:
11.09%
Buy
57
BBIO
BridgeBio Pharma
Last Price:
$36.09
Seasonality Move:
-4.32%
Sell
27
The Chemours (CC)
is a Sell
Is The Chemours a Buy, Sell or Hold?
-
The current The Chemours [CC] share price is $19.91. The Score for CC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
CC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
BridgeBio Pharma (BBIO)
is a Buy
Is BridgeBio Pharma a Buy, Sell or Hold?
-
The current BridgeBio Pharma [BBIO] share price is $36.08. The Score for BBIO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CC Stock Price Chart
What is The Chemours's stock price today?
-
The The Chemours share price today is $19.91Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CC is experiencing slight buying pressure.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $36.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
CC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 62.69 | Buy |
Chaikin Money Flow: | 558028 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.06 - 18.94) | Buy |
Bollinger Bands (100): | (17.77 - 20.47) | Buy |
BBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.11 | Buy |
Relative Strength Index (14 RSI): | 73.73 | Buy |
Chaikin Money Flow: | 2803127 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.41 - 32.55) | Buy |
Bollinger Bands (100): | (24.06 - 29.58) | Buy |
CC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.72 | Buy |
20-day SMA: | 17.86 | Buy |
50-day SMA: | 19.26 | Buy |
200-day SMA: | 21.73 | Sell |
8-day EMA: | 18.88 | Buy |
20-day EMA: | 18.5 | Buy |
50-day EMA: | 18.87 | Buy |
200-day EMA: | 21.5 | Sell |
BBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.36 | Buy |
20-day SMA: | 30.02 | Buy |
50-day SMA: | 27.7 | Buy |
200-day SMA: | 26.76 | Buy |
8-day EMA: | 33.46 | Buy |
20-day EMA: | 31.03 | Buy |
50-day EMA: | 28.68 | Buy |
200-day EMA: | 27.29 | Buy |
The Chemours Earnings Growth & CC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $0.76 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.16 per share, and an increase next year of $0.70 per share.
The Chemours Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BridgeBio Pharma Technical Analysis
Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |